DIANTHUS THERAPEUTICS INC (DNTH) Institutional Ownership and Insiders Activity

DIANTHUS THERAPEUTICS INC (DNTH) is widely held by institutional investors, with 1 tracked firm reporting positions valued at approximately $909,781 based on SEC Form 13F filings for the quarter ended June 30, 2026.

Polen Capital Management is the largest disclosed holder, reporting approximately $909,781 in DNTH holdings in its latest filing.

Institutional ownership among tracked investors remains highly concentrated, with Polen Capital Management representing the majority of disclosed value.

Recent insider activity includes 41 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.